ClassID:

20918

A61K38/1709 - page 11 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Recent Application in this class:
#3001
20150147358
2015-05-28

Methods for modulating immune responses

#3002
20150147347
2015-05-28

Immunotherapy against several tumors including gastrointestinal and gastric cancer

#3003
20150147323
2015-05-28

Modulating the alternative complement pathway

#3004
20150147292
2015-05-28

NOVEL SURFACE MARKERS FOR ADIPOSE TISSUE

#3005
20150141340
2015-05-21

METHOD OF TREATING AND PREVENTING OCULAR ANGIOGENESIS

#3006
20150141334
2015-05-21

COMPOSITION FOR INCREASING MUSCLE MASS AND A PROCESS FOR PRODUCING THE SAME

#3007
20150141330
2015-05-21

Apolipoprotein A-I mimics

#3008
20150141322
2015-05-21

Therapeutic agent, treatment method and inspection method for diseases caused by activation of neutrophils

#3009
20150140070
2015-05-21

Lipid formulations for delivery of messenger RNA

#3010
20150140060
2015-05-21

Compositions and methods for promoting wound healing and tissue regeneration

#3011
20150139995
2015-05-21

Methods and compositions for modulating toso activity

#3012
20150139956
2015-05-21

Compositions which regulate the epithelial brush border Na/H exchanger NHE3 and their methods of use in gastrointestinal disease

#3013
20150139937
2015-05-21

Methods and compositions for inhibiting diseases of the central nervous system

#3014
20150133389
2015-05-14

Methods of treatment of cancer using SRC-modulating peptides

#3015
20150132279
2015-05-14

RADIATION STERILIZATION-RESISTANT PROTEIN COMPOSITION

#3016
20150132262
2015-05-14

Mutant adeno-associated virus virions and methods of use thereof

#3017
20150126582
2015-05-07

Combination Treatment of Multiple Myeloma

#3018
20150126501
2015-05-07

Fused ring compound for use as mineralocorticoid receptor antagonist

#3019
20150126443
2015-05-07

Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes

#3020
20150125490
2015-05-07

Compositions and methods for lung regeneration

#3021
20150119343
2015-04-30

Production of TSG-6 Protein

#3022
20150119331
2015-04-30

Use of Histones for Therapeutic Purposes

#3023
20150119326
2015-04-30

Administration of angiocidin for arresting the growth of a tumor cell

#3024
20150118253
2015-04-30

Methods and compositions for the treatment of cancer and infectious disease using alpha(2) macroglobulin-antigenic molecule complexes

#3025
20150118230
2015-04-30

Pharmaceutical use of FAM19A5 involved in regulating gliogenesis

#3026
20150111835
2015-04-23

Modified peptides and their use for treating autoimmune diseases

#3027
20150111830
2015-04-23

Methods and compositions for activation of sirtuins with Annexin A1 peptides

#3028
20150111822
2015-04-23

WNT7A compositions and method of using the same

#3029
20150110857
2015-04-23

CNS DELIVERY OF MRNA AND USES THEREOF

#3030
20150110813
2015-04-23

Methods of preventing rejection of transplanted tissue by administering anti-CD40L antibody and dendritic cells loaded with type B peptide

#3031
20150110807
2015-04-23

hDC-sign binding peptides

#3032
20150110778
2015-04-23

COMPOSITIONS COMPRISING MG53 AND METHODS FOR THE TREATMENT AND PREVENTION OF AIRWAY INJURY

#3033
20150105325
2015-04-16

Method of reducing cancer cell proliferation by administering recombinant alpha-fetoprotein

#3034
20150105322
2015-04-16

Non-N-glycosylated recombinant human annexin A2

#3035
20150104425
2015-04-16

Medical food for high cortisol breast cancer

#3036
20150104414
2015-04-16

Cytokines and neuroantigens for treatment of immune disorders

#3037
20150099695
2015-04-09

C1q/TNF-RELATED PROTEIN-9 (CTRP9) AND USE IN PREVENTION AND TREATMENT OF METABOLIC DISORDERS

#3038
20150098938
2015-04-09

Modulators of acyl-CoA lysocardiolipin acyltransferase 1 (ALCAT1) and uses thereof

#3039
20150094257
2015-04-02

USE OF NUTRITIONAL COMPOSITIONS FOR PREVENTING DISORDERS

#3040
20150094256
2015-04-02

Use of the cathelicidin LL-37 and derivatives thereof for wound healing

#3041
20150093459
2015-04-02

BIOACTIVE COMPLEX COMPOSITIONS AND METHODS OF USE THEREOF

#3042
20150093400
2015-04-02

Peptides for management of lactation

#3043
20150093383
2015-04-02

Use of immunesuppressant receptor

#3044
20150093334
2015-04-02

Vault and vault like carrier molecules

#3045
20150087592
2015-03-26

Sugar compositions for treating hemophilia A and/or von Willebrand disease

#3046
20150087589
2015-03-26

Genes and proteins associated with angiogenesis and uses thereof

#3047
20150086648
2015-03-26

METHODS FOR TREATING HEAT STRESS AND RELATED COMPOSITIONS

#3048
20150080315
2015-03-19

Spalt-like transcription factor 4 (SALL4) and uses thereof

#3049
20150080313
2015-03-19

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MULTIPLE SCLEROSIS

#3050
20150079110
2015-03-19

REGENERATION OF INNER EAR CELLS

#3051
20150079083
2015-03-19

Alpha B-Crystallin as a Therapy for Ischemia or Inflammation

#3052
20150079062
2015-03-19

METHOD FOR HARVESTING, PROCESSING, AND STORAGE OF PROTEINS FROM THE MAMMALIAN FETO-PLACENTAL UNIT AND USE OF SUCH PROTEINS IN COMPOSITIONS AND MEDICAL TREATMENT

#3053
20150079061
2015-03-19

METHOD FOR THE HARVESTING, PROCESSING, AND STORAGE OF PROTEINS FROM THE MAMMALIAN FETO-PLACENTAL UNIT AND USE OF SUCH PROTEINS IN COMPOSITIONS AND MEDICAL TREATMENT

#3054
20150079051
2015-03-19

TFEB GENE THERAPY OF ALPHA-1-ANTITRYPSIN DEFICIENCY

#3055
20150079038
2015-03-19

Recombinant AAV capsid protein

#3056
20150073053
2015-03-12

Treatment of drug resistant cancer

#3057
20150072927
2015-03-12

Methods and compositions to regulate hepcidin expression

#3058
20150072925
2015-03-12

Methods for weight loss and ketogenic compositions

#3059
20150072922
2015-03-12

RNASE 7 ANTIMICROBIAL PEPTIDES

#3060
20150072019
2015-03-12

FGFR INHIBITOR FOR USE IN THE TREATMENT OF HYPOPHOSPHATEMIC DISORDERS

#3061
20150071988
2015-03-12

Sterically Stabilized Carrier For Aerosol Therapeutics, Compositions And Methods For Treating The Respiratory Tract Of A Mammal

#3062
20150071986
2015-03-12

Method for blocking tumour growth

#3063
20150065434
2015-03-05

Cyclic peptide inhibitors of lysine-specific demethylase 1

#3064
20150064255
2015-03-05

NANOSTRUCTURES FOR TREATING CANCERS AND OTHER CONDITIONS

#3065
20150064134
2015-03-05

Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition

#3066
20150057231
2015-02-26

Use of engrailed proteins for increasing dopamine synthesis by dopaminergic neurons

#3067
20150057229
2015-02-26

Method of treating bone disorders using TSG-6

#3068
20150057221
2015-02-26

PRODRUG COMPRISING A DRUG LINKER CONJUGATE

#3069
20150056700
2015-02-26

Bone morphogenic protein binding peptide

#3070
20150056299
2015-02-26

FOOD SUPPLEMENT TO SUPPORT BRAIN FUNCTION

#3071
20150051140
2015-02-19

MODIFICATION OF FEEDING BEHAVIOR

#3072
20150051137
2015-02-19

Peptide and uses therefor

#3073
20150050249
2015-02-19

Enhancement of osteogenic potential of bone grafts

#3074
20150050215
2015-02-19

Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease

#3075
20150045296
2015-02-12

Method for treating diabetic retinopathy

#3076
20150045295
2015-02-12

Dry powder inhaler and system for drug delivery

#3077
20150045292
2015-02-12

Methods and composition for inducing satiety

#3078
20150044260
2015-02-12

NANOPARTICLE AGGREGATES CONTAINING OSTEOPONTIN AND CALCIUM- AND/OR STRONTIUM-CONTAINING PARTICLES

#3079
20150038557
2015-02-05

METHODS AND COMPOSITIONS FOR TREATMENT OF RETINAL DEGENERATIVE DISEASES

#3080
20150038419
2015-02-05

Simukunin

#3081
20150037330
2015-02-05

Histamine-releasing factor (HRF), HRF-receptor and methods of modulating inflammation

#3082
20150037325
2015-02-05

ROBO2 inhibitory compositions comprising SLIT2-binding extracellular domain of ROBO2

#3083
20150037294
2015-02-05

Methods for promoting wound healing and muscle regeneration with the cell signaling protein nell1

#3084
20150031626
2015-01-29

ADAM22 for use as a prognostic variable, and target for therapy, of a metastatic breast cancer disease

#3085
20150030568
2015-01-29

Use of stem cells to generate inner ear cells

#3086
20150025501
2015-01-22

Composition and method for the treatment or prevention of spinal disorders

#3087
20150025018
2015-01-22

Method for inhibiting euPTX3 to treat nasopharyngeal carcinoma by amino acid sequence

#3088
20150025014
2015-01-22

Treatment of amyloidoses using myelin basic protein and fragments thereof

#3089
20150024030
2015-01-22

Protection against and treatment of ionizing radiation

#3090
20150023971
2015-01-22

Modulation of activity of proneurotrophins

#3091
20150023970
2015-01-22

ActRIIB proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy

#3092
20150023955
2015-01-22

Treatment and diagnosis of melanoma

#3093
20150023949
2015-01-22

COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER

#3094
20150018284
2015-01-15

Formulations and methods of use for alpha connexin C-terminal (ACT) peptides

#3095
20150018278
2015-01-15

Phosphorylation on the Thr-248 and/or Thr-250 residues of transcription factor E2F4 as a therapeutic target in pathological processes associated with somatic polyploidy

#3096
20150018267
2015-01-15

Endomucin as an anti-inflammatory agent

#3097
20150017727
2015-01-15

Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues

#3098
20150017255
2015-01-15

Methods for treating cardiac conditions

#3099
20150017134
2015-01-15

EMT-INDUCING TRANSCRIPTION FACTORS COOPERATE WITH SOX9

#3100
20150011482
2015-01-08

Nutritive fragments, proteins and methods

#3101
20150011471
2015-01-08

REGENERATION OF ISLET BETA CELLS BY HSP60 DERIVED PEPTIDES

#3102
20150011469
2015-01-08

Method of treating diabetes using non-glycosylated apolipoprotein A-IV

#3103
20150011468
2015-01-08

USES OF CASEIN COMPOSITIONS

#3104
20150010576
2015-01-08

Method of identifying a compound for treating a hypoxic or ischemic related disorder

#3105
20150010531
2015-01-08

Compounds and methods for the treatment of vascular disease

#3106
20150005240
2015-01-01

THERAPEUTIC METHOD OF TREATMENT FOR INHIBITING TUMOR DEVELOPMENT USING TAMM-HORSFALL GLYCOPROTEIN (THP) AS IMMUNOSTIMULATING DRUG AND COMPOSITIONS

#3107
20150005227
2015-01-01

METHOD OF TREATING AN ISCHEMIA-REPERFUSION INJURY-RELATED DISORDER BY ADMINISTERING GPCR LIGANDS

#3108
20150004220
2015-01-01

Methods of reducing the effects of exposure to a mustard compound by administering RLIP76

#3109
20140378394
2014-12-25

METHODS FOR TREATING ERECTILE DYSFUNCTION IN PATIENTS WITH INSULIN-DEPENDENT DIABETES

#3110
20140377360
2014-12-25

Composition for controlled release of physiologically active substance

#3111
20140377339
2014-12-25

TUSC2 therapies

#3112
20140377259
2014-12-25

METHODS FOR INHIBITING HIV-1 REPLICATION INVOLVING THE ADMINISTRATION OF AN ANTI-CCR5 RECEPTOR MONOCLONAL ANTIBODY AND SMALL MOLECULE CCR5 RECEPTOR ANTAGONIST

#3113
20140371160
2014-12-18

Alpha-1 antitrypsin variant, preparation method thereof and use thereof

#3114
20140371151
2014-12-18

Use of liposomal WNT composition to enhance osseointegration

#3115
20140371142
2014-12-18

Myonectin (CTRP15), compositions comprising same, and methods of use

#3116
20140370044
2014-12-18

Modified epitopes for boosting CD4+ T-cell responses

#3117
20140369971
2014-12-18

Method and composition for inducing human pluripotent stem cells

#3118
20140364363
2014-12-11

Glypican-4 based compositions and methods for treating and diagnosing insulin resistance

#3119
20140363450
2014-12-11

Oxidized cardiolipin as a pro-inflammatory factor

#3120
20140357703
2014-12-04

Method of reducing cell death by administering a nucleic acid encoding a paracrine factor of a mesenchymal stem cell

#3121
20140357578
2014-12-04

Therapeutic approach for polyglutamine degeneration

#3122
20140357576
2014-12-04

METHODS FOR ENHANCEMENT OF MUSCLE PROTEIN SYNTHESIS

#3123
20140357553
2014-12-04

NUTRITIONAL COMPOSITION FOR WOUND HEALING

#3124
20140357548
2014-12-04

Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors

#3125
20140356380
2014-12-04

Neutralizing antibodies and methods of use thereof

#3126
20140348812
2014-11-27

PROTOCOLS FOR TREATING AND PREVENTING OBESITY AND COMPLICATIONS ARISING THEREFROM

#3127
20140348784
2014-11-27

COMPOSITIONS AND METHODS FOR TREATMENT OF ANGIOGENESIS IN PATHOLOGICAL LESIONS

#3128
20140342995
2014-11-20

Method for treating brain cancer using a novel tumor suppressor gene and secreted factor

#3129
20140342988
2014-11-20

Adrenomedullin and adrenomedullin binding protein for ischemia/reperfusion treatment

#3130
20140336130
2014-11-13

TARGETING EN2, PAX2, AND/OR DEFB1 FOR TREATMENT OF PROSTATE CONDITIONS

#3131
20140336122
2014-11-13

Removal of serine proteases by treatment with finely divided silicon dioxide

#3132
20140336121
2014-11-13

Factor H for treatment of rheumatoid arthritis

#3133
20140336111
2014-11-13

Therapeutic use of activators of zinc finger protein GL13

#3134
20140336104
2014-11-13

ACTH prophylactic treatment of renal disorders

#3135
20140335152
2014-11-13

Methods and compositions for enhancing the uptake of therapeutic agents by target cells

#3136
20140335113
2014-11-13

Factor H for transplantation

#3137
20140335108
2014-11-13

UTILITY OF INSULIN-LIKE 6 (INSL6) FOR THE TREATMENT OF AUTOIMMUNE DISEASES

#3138
20140335088
2014-11-13

Antibodies and vaccines for use in therapeutic and diagnostic methods for α-synuclein-related disorders

#3139
20140335078
2014-11-13

Use Of Complement Inhibitors To Treat Ocular Diseases

#3140
20140335064
2014-11-13

Human skin equivalents expressing exogenous polypeptides

#3141
20140335018
2014-11-13

Pharmaceutical composition comprising modified hemoglobin-based therapeutic agent for cancer targeting treatment and diagnostic imaging

#3142
20140329742
2014-11-06

Peptide YY analogs

#3143
20140323413
2014-10-30

METHODS OF DIAGNOSING AND TREATING VASCULAR ASSOCIATED MACULOPATHY AND SYMPTOMS THEREOF

#3144
20140323410
2014-10-30

Use of HDL-related molecules to treat and prevent proinflammatory conditions

#3145
20140323400
2014-10-30

Use of fibromodulin and lumican for increasing muscle mass

#3146
20140322241
2014-10-30

Methods of regulating angiogenesis by administering agents which increase apoB-100 polypeptide

#3147
20140322176
2014-10-30

Methods of using ZSCAN4 for rejuvenating human cells

#3148
20140322162
2014-10-30

Use of Ferritin to Treat Iron Disorders

#3149
20140316112
2014-10-23

Method of increasing the hydrodynamic volume of polypeptides by attaching to gonadotrophin carboxy terminal peptides

#3150
20140315814
2014-10-23

Synthetic pentasaccharides having short half-life and high activity

#3151
20140315813
2014-10-23

Use of an Active Biological Substance in Abnormal Cellular and Viral Membrane Physiologies

#3152
20140315806
2014-10-23

Veterinary decorin compositions and use thereof

#3153
20140314759
2014-10-23

Isolated nucleotide sequences encoding GDF traps

#3154
20140314758
2014-10-23

Immunogenic tumor associated stromal cell antigen peptides and methods of their use

#3155
20140314663
2014-10-23

PEPTIDE-MEDIATED DELIVERY OF ACTIVE AGENTS ACROSS THE BLOOD-BRAIN BARRIER

#3156
20140311482
2014-10-23

Rhinosinusitis Prevention and Therapy with Proinflammatory Cytokine Inhibitors

#3157
20140309177
2014-10-16

Compositions and methods for the induction and tuning of gene expression

#3158
20140309167
2014-10-16

COMBINATION OF ACTIVE INGREDIENTS FOR THE TREATMENT OF ACUTE KIDNEY INJURY

#3159
20140308744
2014-10-16

Compositions of active Wnt protein

#3160
20140308369
2014-10-16

Dietary product intended to reduce visceral fat during the pre-operative phase prior to bariatric surgery

#3161
20140308306
2014-10-16

Methods for treating kidney disease with fragments of ApoB-100

#3162
20140308299
2014-10-16

Combination immunotherapy for the treatment of cancer

#3163
20140308289
2014-10-16

Extracellular histones as biomarkers for prognosis and molecular targets for therapy

#3164
20140308275
2014-10-16

METHODS FOR DIAGNOSING AND TREATING MYHRE SYNDROME

#3165
20140308262
2014-10-16

Mitochondrial proteins constructs and uses thereof

#3166
20140308260
2014-10-16

METHODS AND COMPOSITIONS COMPRISING A NITRITE-REDUCTASE PROMOTER FOR TREATMENT OF MEDICAL DISORDERS AND PRESERVATION OF BLOOD PRODUCTS

#3167
20140308240
2014-10-16

Therapeutic agent for infections, and treatment method using same

#3168
20140303160
2014-10-09

Targeting GLI proteins in human cancer by small molecules

#3169
20140303087
2014-10-09

Treating cartilage defect with UCB-MSC expressing TSP-2

#3170
20140303086
2014-10-09

Endothelium protective materials and methods of use

#3171
20140303081
2014-10-09

Apoptosis-targeting nanoparticles

#3172
20140303079
2014-10-09

Delaying the progression of diabetes

#3173
20140303068
2014-10-09

METHOD OF TREATING MUCUS HYPERSECRETION

#3174
20140302171
2014-10-09

Cysteine Peptide-Containing Health Drink

#3175
20140302111
2014-10-09

COMPOSITIONS AND METHODS FOR DENTAL TISSUE REGENERATION

#3176
20140301983
2014-10-09

Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use

#3177
20140296159
2014-10-02

Method for therapeutic replenishment and enrichment of ocular surface lubrication

#3178
20140296154
2014-10-02

METHOD OF PREVENTING DEVELOPMENT OF PSORIATIC LESIONS

#3179
20140296152
2014-10-02

Method of reducing cell death by administering a paracrine factor derived from a mesenchymal stem cell

#3180
20140296149
2014-10-02

Compositions and methods for the treatment of cardiac surgery-associated acute kidney injury with annexin A1 peptide

#3181
20140296135
2014-10-02

MEDICAMENT FOR THE TREATMENT OF FUNGAL INFECTIONS PARTICULARLY ASPERGILLOSIS

#3182
20140294726
2014-10-02

METHODS FOR DIAGNOSING AND TREATING ALZHEIMER'S DISEASE BY ADMINISTERING AN ANTI-ANGIOGENIC AGENT

#3183
20140290647
2014-10-02

Intranasal administration of agents with pro-inflammatory activity for the therapy of neurological disorders

#3184
20140288178
2014-09-25

Inhibition of c-Myc ubiquitination to prevent cancer initiation and progression

#3185
20140288162
2014-09-25

Methods, compositions and screens for therapeutics for the treatment of synovial sarcoma

#3186
20140287057
2014-09-25

Dietary product intended for the prevention of cardiometabolic risk

#3187
20140287033
2014-09-25

Lipid therapy

#3188
20140286932
2014-09-25

Giant obscurins and uses thereof in cancer prognosis and therapy

#3189
20140286928
2014-09-25

Treatment of heart disease by inhibition of the action of ribosomal S6 kinase 3 (RSK3)

#3190
20140286914
2014-09-25

Protein therapy for treatment of retinal diseases

#3191
20140286859
2014-09-25

PSMA antibodies and uses thereof

#3192
20140274915
2014-09-18

Methods of Use for Recombinant Human Secretoglobins

#3193
20140274891
2014-09-18

METHOD OF GENERATING AN INDEX SCORE FOR MBL DEFICIENCY TO PREDICT CARDIODIABETES RISK

#3194
20140274753
2014-09-18

Epigenetic biomarker ZNF545 for diagnosing and prognosis of gastric cancer

#3195
20140273204
2014-09-18

Vectors encoding a paralytic peptide

#3196
20140271554
2014-09-18

Reducing proinflammatory response

#3197
20140271552
2014-09-18

Nutritional compositions containing a peptide component and uses thereof

#3198
20140256795
2014-09-11

Co-activation of mTOR and STAT3 pathways to promote neuronal survival and regeneration

#3199
20140256653
2014-09-11

WHEY PROTEIN MICELLES TO ENHANCE MUSCLE MASS AND PERFORMANCE

#3200
20140255477
2014-09-11

Compositions and Methods for Delivery of High-Affinity Oxygen Binding Agents to Tumors

#3201
20140255362
2014-09-11

SRPX for treatment of cancer

#3202
20140255337
2014-09-11

Methods of treating cognitive impairment

#3203
20140255310
2014-09-11

Human G Protein-Coupled Receptor and Modulators Thereof for the Treatment of Atherosclerosis and Atherosclerotic Disease and for the Treatment of Conditions Related to MCP-1 Expression

#3204
20140249087
2014-09-04

USE OF HEMOPEXIN TO SEQUESTER HEMOGLOBIN

#3205
20140249081
2014-09-04

Nanoparticle peptide compositions

#3206
20140249078
2014-09-04

WHEY PROTEIN MICELLES AGAINST MUSCLE ATROPHY AND SARCOPENIA

#3207
20140243272
2014-08-28

Compound and method for treatment of Alzheimer's disease

#3208
20140242142
2014-08-28

Cell secreted proteins for the treatment of myocardial infarction

#3209
20140242086
2014-08-28

Antibodies which bind to signal peptide-containing molecules

#3210
20140235544
2014-08-21

DISEASE TREATMENT VIA ANTIMICROBIAL PEPTIDES OR THEIR INHIBITORS

#3211
20140235526
2014-08-21

Methods for generating cardiomyocytes

#3212
20140234405
2014-08-21

INSULIN INDEPENDENCE AMONG PATIENTS WITH DIABETES UTILIZING A PPI IN COMBINATION WITH AN IMMUNE TOLERANCE AGENT

#3213
20140234287
2014-08-21

SUMOYLATION OF SERCA2a AND CARDIOVASCULAR DISEASE

#3214
20140228299
2014-08-14

PROPHYLACTIC AND THERAPEUTIC AGENT FOR NEUROLOGICAL DISEASES USING LIPOPROTEINS AND PROPHYLACTIC AND THERAPEUTIC METHOD FOR NEUROLOGICAL DISEASES

#3215
20140227350
2014-08-14

Annexin A2 and tissue plasminogen activator for treating vascular disease

#3216
20140227280
2014-08-14

Protein complex comprising MCM8 and MCM9 proteins and their use

#3217
20140227254
2014-08-14

Antagonists of BMP9, BMP10, ALK1 and other ALK1 ligands, and uses thereof

#3218
20140227232
2014-08-14

Methods and compositions for delivery of exogenous factors to nervous system sites

#3219
20140227186
2014-08-14

Nanoparticle delivery compositions

#3220
20140227172
2014-08-14

Diagnosis and treatment of prostate cancer

#3221
20140220025
2014-08-07

STIP1 polypeptides and uses thereof

#3222
20140219988
2014-08-07

RRECOMBINANT HUMAN SAPOSIN B PROTEIN CONTAINING PHOSPHORYLATED GLUCOSE RING AND USE THEREOF

#3223
20140219979
2014-08-07

HSP60, HSP60 PEPTIDES AND T CELL VACCINES FOR IMMUNOMODULATION

#3224
20140213530
2014-07-31

Methods for treatment of cancer by targeting Sirt5

#3225
20140213505
2014-07-31

Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion

#3226
20140212510
2014-07-31

CAPCNA peptide therapeutics for cancer

#3227
20140212436
2014-07-31

Rapid clearance of antigen complexes using novel antibodies

#3228
20140206600
2014-07-24

Charged lipoprotein complexes and their uses

#3229
20140205618
2014-07-24

HUMAN FERTILITY ENHANCEMENT WITH CORTISOL REDUCTION FOOD

#3230
20140205588
2014-07-24

Plasminogen and plasmin variants

#3231
20140194368
2014-07-10

Method of Treating Cancer by Administration of Low Levels of Heat Shock Protein 70 (HSP70)

#3232
20140194364
2014-07-10

Biomarkers for Painful Intervertebral Discs and Methods of Use Thereof

#3233
20140194343
2014-07-10

CTRP6 which can be used as therapeutic and prophylactic agent for autoimmune diseases

#3234
20140194340
2014-07-10

DIAGNOSING, MONITORING AND TREATING INFLAMMATION

#3235
20140193425
2014-07-10

TREATMENT OF CANCER WITH ALK1 ANTAGONISTS

#3236
20140193393
2014-07-10

Methods for treatment of stroke or cerebrovascular accidents using an ETreceptor agonist

#3237
20140187608
2014-07-03

Inhibitor of neuronal connectivity linked to schizophrenia susceptibility and cognitive dysfunction

#3238
20140187498
2014-07-03

Predicting and treating diabetic complications

#3239
20140187496
2014-07-03

SGEF CONTROLS MACULAR, CORPUS CALLOSUM AND HIPPOCAMPAL FUNCTION AND DEVELOPMENT, LIVER HOMEOSTASIS, FUNCTIONS OF THE IMMUNE SYSTEM, FEVER RESPONSE ATHEROSCLEROSIS AND TUMOROGENIC CELL GROWTH

#3240
20140186294
2014-07-03

PHAGOCYTIC ACTIVITY AS A MARKER OF SYNUCLEINOPATHIC DISEASE

#3241
20140179610
2014-06-26

Treatment of myocardial injury with humanin analogs

#3242
20140179600
2014-06-26

Stable formulations for parenteral injection of peptide drugs

#3243
20140179599
2014-06-26

Stable formulations for parenteral injection of peptide drugs

#3244
20140179595
2014-06-26

Apolipoprotein E polypeptides and their use

#3245
20140178403
2014-06-26

Method of inhibiting binding or activity of MIF by administering a MIF antagonist

#3246
20140178370
2014-06-26

Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway

#3247
20140178309
2014-06-26

Protection of cells from -RNA-induced degeneration and inhibitors for protecting cells

#3248
20140171374
2014-06-19

USE OF A TRUNCATED EIF-5A1 POLYNUCLEOTIDE TO INDUCE APOPTOSIS IN CANCER CELLS

#3249
20140171367
2014-06-19

Polymer hydrogels for in vivo applications and methods for using and preparing same

#3250
20140171362
2014-06-19

Stable formulations for parenteral injection of peptide drugs

#3251
20140170177
2014-06-19

Food supplement having high immunological value, based on a protein matrix

#3252
20140170162
2014-06-19

PRESERVATION OF THE NEUROMUSCULAR JUNCTION (NMJ) AFTER TRAUMATIC NERVE INJURY

#3253
20140165223
2014-06-12

TNF SUPERFAMILY TRIMERIZATION INHIBITORS

#3254
20140162960
2014-06-12

Scaffold-kinase interaction blockades and uses thereof in treating cancer

#3255
20140162952
2014-06-12

ERAP1-derived peptide and use thereof

#3256
20140162948
2014-06-12

FORMULATION FOR INCREASING BIOAVAILABILITY OF NEURTURIN

#3257
20140161824
2014-06-12

Methods and compositions relating to P62 for the treatment and prophylaxis of cancer

#3258
20140161805
2014-06-12

Methods for Manipulating Phagocytosis Mediated by CD47

#3259
20140161773
2014-06-12

Use of an agent that restores tissue perfusion and oxygenation

#3260
20140155333
2014-06-05

Compositions and methods for cancer treatment using targeted carbon nanotubes

#3261
20140155314
2014-06-05

Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion

#3262
20140148391
2014-05-29

Use of histones for therapeutic purposes

#3263
20140148386
2014-05-29

Method for treatment of diabetic vascular leakage-induced disease using C-peptide

#3264
20140147917
2014-05-29

REIC-expressing adenovirus vector

#3265
20140147492
2014-05-29

METHODS AND COMPOSITIONS FOR ENHANCING THE UPTAKE OF THERAPEUTIC AGENTS BY TARGET CELLS

#3266
20140147445
2014-05-29

Selective targeting of the CD40L/Mac-1 interaction by small peptide inhibitors and its use for the treatment of inflammation and atherogenesis

#3267
20140142284
2014-05-22

Manufacturing and purification processes of Complex protein found in Fraction IV to make a separated Apo, Transferrin, and Alpha 1 Antitrypsin (A1AT) or a combined Transferrin/Apo/Human Albumin/A1AT and all new found proteins

#3268
20140142045
2014-05-22

USE OF REGULATOR OF CALCINEURIN 1 FOR MANUFACTURING MEDICAMENT FOR TREATMENT OF DISEASES ASSOCIATED WITH INCREASED NF-KB ACTIVITY

#3269
20140140992
2014-05-22

Sustained release formulations for delivery of proteins to the eye and methods of preparing same

#3270
20140140987
2014-05-22

Manufacturing and Purification Processes of Complex Protein found in Fraction IV to make a separated Apo, Transferrin, and Alpha 1 Anti strepsin (A1AT) or A combined Transferrin/Apo/Human Albumin/A1AT and all new found proteins

#3271
20140135275
2014-05-15

Mitochondrial targeting and therapeutic use thereof

#3272
20140135257
2014-05-15

Use of a nucleotide for improving the heat stability of an aqueous micellar casein composition

#3273
20140135256
2014-05-15

Treatment of extracellular matrix to reduce inflammation

#3274
20140134276
2014-05-15

Anti-tumor drug, medicament, composition, and use thereof

#3275
20140134237
2014-05-15

Type I interferon mimetics as therapeutics for cancer, viral infections, and multiple sclerosis

#3276
20140134231
2014-05-15

MIR-211 EXPRESSION AND RELATED PATHWAYS IN HUMAN MELANOMA

#3277
20140134188
2014-05-15

Methods for P2RY5 Mediated Regulation of Hair Growth and Mutants Thereof

#3278
20140128323
2014-05-08

Method for prevention or treatment of diabetic angiogenesis impairment using C-peptide

#3279
20140128322
2014-05-08

Methods for promoting neuronal outgrowth by insulin-like growth factor binding protein-like 1 (IGFBPL-1) in glaucoma or leber's optic neuropathy

#3280
20140127134
2014-05-08

Treatment and prevention of cancer with HMGB1 antagonists

#3281
20140120059
2014-05-01

IMMUNITY INDUCING AGENT

#3282
20140114050
2014-04-24

Use of peptides for promoting wound healing

#3283
20140113867
2014-04-24

APLs for treating arthritis

#3284
20140113857
2014-04-24

Targeting deregulated Wnt signaling in cancer using stabilized alpha-helices of BCL-9

#3285
20140107391
2014-04-17

Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality

#3286
20140107029
2014-04-17

Methods and Apparatus for Creating Particle Derivatives of HDL with Reduced Lipid Content

#3287
20140105939
2014-04-17

Methods and compositions for modulating myofibroblast activities

#3288
20140099343
2014-04-10

Ophthalmic device, and method of use thereof, for increasing ocular boundary lubrication

#3289
20140094506
2014-04-03

USE OF LIGHT SENSITIVE GENES

#3290
20140094416
2014-04-03

SPARC ANGIOGENIC DOMAIN AND METHODS OF USE

#3291
20140093515
2014-04-03

PROCESS OF AFOD AND AFCC AND MANUFACTURING AND PURIFICATION PROCESSES OF PROTEINS

#3292
20140093490
2014-04-03

Method for screening a glutamate release inhibitor in an astrocyte

#3293
20140088176
2014-03-27

GENE TRANSFER FOR REGULATING SMOOTH MUSCLE TONE

#3294
20140088018
2014-03-27

Compositions and methods for treatment of gynecologic cancers

#3295
20140086979
2014-03-27

Self-assembling nanoparticles for the release of bisphosphonates in the treatment of human cancers

#3296
20140086918
2014-03-27

Methods for treating castration resistant prostate cancer and metastasis by reducing B-cell number and/or function

#3297
20140083421
2014-03-27

Dry powder inhaler and system for drug delivery

#3298
20140079729
2014-03-20

METHOD FOR IMPROVING ENDOTHELIAL FUNCTION AND DECREASING CARDIOVASCULAR MORBIDITY USING SHILAJIT

#3299
20140072613
2014-03-13

Compositions and Methods for Treating Cutaneous Scarring

#3300
20140072558
2014-03-13

Activin Receptor Type II B Inhibitors Comprising DLK1 Extracellular Water-Soluble Domain